Review article: colitis-associated cancer -- time for new strategies. (Q35209646)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12950414%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Review article: colitis-associated cancer -- time for new strategies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12950414%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12950414%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

Shanahan F

series ordinal

1

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12950414%20AND%20SRC:MED&resulttype=core&format=json

Alimentary Pharmacology & Therapeutics

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12950414%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

18 Suppl 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12950414%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

6-9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12950414%20AND%20SRC:MED&resulttype=core&format=json

The risk of colorectal cancer in ulcerative colitis: a meta-analysis

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.18.S2.5.X

Increased risk of large-bowel cancer in Crohn's disease with colonic involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.18.S2.5.X

The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.18.S2.5.X

Colorectal cancer prevention in ulcerative colitis: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.18.S2.5.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.18.S2.5.X

Unifying hypothesis for inflammatory bowel disease and associated colon cancer: sticking the pieces together with sugar

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.18.S2.5.X

At the crossroads of inflammation and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.18.S2.5.X

A proinflammatory cytokine inhibits p53 tumor suppressor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.18.S2.5.X

Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.18.S2.5.X

Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.18.S2.5.X

Translational medicine: targetting cyclo-oxygenase isozymes to prevent cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.18.S2.5.X

Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.18.S2.5.X

The indigenous gastrointestinal microflora

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.18.S2.5.X

Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.18.S2.5.X